Works matching IS 03065251 AND DT 2018 AND VI 84 AND IP 1

Results: 23

Co-administration of cyclosporine and ticagrelor may lead to a higher exposure to cyclosporine: a case report of a 49-year-old man.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 208, doi. 10.1111/bcp.13433

By:

van Sloten, Thomas T.;
de Klaver, Paul A. G.;
van den Wall Bake, A. Warmold L.

Publication type:

Article

Issue highlights.

Published in:: 2018
Publication type:: Other

Global population pharmacokinetics of the investigational Aurora A kinase inhibitor alisertib in cancer patients: rationale for lower dosage in Asia.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 35, doi. 10.1111/bcp.13430

By:

Zhou, Xiaofei;
Mould, Diane R.;
Takubo, Takatoshi;
Sheldon‐Waniga, Emily;
Huebner, Dirk;
Milton, Ashley;
Venkatakrishnan, Karthik

Publication type:

Article

External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 153, doi. 10.1111/bcp.13431

By:

Mao, Jun‐Jun;
Jiao, Zheng;
Yun, Hwi‐Yeol;
Zhao, Chen‐Yan;
Chen, Han‐Chao;
Qiu, Xiao‐Yan;
Zhong, Ming‐Kang

Publication type:

Article

Renal function monitoring in heart failure - what is the optimal frequency? A narrative review.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 5, doi. 10.1111/bcp.13434

By:

Al‐Naher, Ahmed;
Wright, David;
Devonald, Mark Alexander John;
Pirmohamed, Munir

Publication type:

Article

Phenytoin: its potential as neuroprotective and retinoprotective drug.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 195, doi. 10.1111/bcp.13435

By:

Chiosi, Flavia;
Keppel Hesselink, Jan;
Rinaldi, Michele;
Di Staso, Silvio;
Bartollino, Silvia;
Costagliola, Ciro

Publication type:

Article

Pharmacodynamics and pharmacokinetics of ticagrelor vs. clopidogrel in patients with acute coronary syndromes and chronic kidney disease.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 88, doi. 10.1111/bcp.13436

By:

Wang, Heyang;
Qi, Jing;
Li, Yi;
Tang, Yunbiao;
Li, Chao;
Li, Jing;
Han, Yaling

Publication type:

Article

Short- and long-term complications of in utero exposure to lamotrigine.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 189, doi. 10.1111/bcp.13437

By:

Cohen‐Israel, Merav;
Berger, Itai;
Martonovich, Einat Y.;
Klinger, Gil;
Stahl, Bracha;
Linder, Nehama

Publication type:

Article

Pharmacokinetic interactions and dosing rationale for antiepileptic drugs in adults and children.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 97, doi. 10.1111/bcp.13400

By:

van Dijkman, Sven C.;
Rauwé, Willem M.;
Danhof, Meindert;
Della Pasqua, Oscar

Publication type:

Article

Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 197, doi. 10.1111/bcp.13401

By:

Allegra, Sarah;
Fatiguso, Giovanna;
De Francia, Silvia;
Favata, Fabio;
Pirro, Elisa;
Carcieri, Chiara;
De Nicolò, Amedeo;
Cusato, Jessica;
Di Perri, Giovanni;
D'Avolio, Antonio

Publication type:

Article

Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 18, doi. 10.1111/bcp.13402

By:

de Jager, Rosa L.;
van Maarseveen, Erik M.;
Bots, Michiel L.;
Blankestijn, Peter J.;
on behalf of the SYMPATHY investigators

Publication type:

Article

Population pharmacokinetics of the MEK inhibitor selumetinib and its active N-desmethyl metabolite: data from 10 phase I trials.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 52, doi. 10.1111/bcp.13404

By:

Patel, Parul;
Howgate, Eleanor;
Martin, Paul;
Carlile, David J.;
Aarons, Leon;
Zhou, Diansong

Publication type:

Article

Safety, tolerability, and pharmacokinetics of radavirsen (AVI-7100), an antisense oligonucleotide targeting influenza a M1/M2 translation.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 25, doi. 10.1111/bcp.13405

By:

Beigel, John H.;
Voell, Jocelyn;
Muñoz, Paula;
Kumar, Parag;
Brooks, Kristina M.;
Zhang, Jianbo;
Iversen, Patrick;
Heald, Alison;
Wong, Michael;
Davey, Richard T.

Publication type:

Article

Noncholestatic acute hepatocellular injury following candesartan administration.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 204, doi. 10.1111/bcp.13406

By:

Lammel‐Lindemann, Jan Antonio;
Flores‐Villalba, Eduardo;
Martagón, Alexandro Jose;
DeObeso‐Gonzalez, Eduardo;
Puente‐Gallegos, Francisco

Publication type:

Article

Issue Information.

Published in:: British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 1, doi. 10.1111/bcp.13407
Publication type:: Article

Adulteration of proprietary Chinese medicines and health products with undeclared drugs: experience of a tertiary toxicology laboratory in Hong Kong.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 172, doi. 10.1111/bcp.13420

By:

Ching, Chor Kwan;
Chen, Sammy Pak Lam;
Lee, Hencher Han Chih;
Lam, Ying Hoo;
Ng, Sau Wah;
Chen, Mo Lung;
Tang, Magdalene Huen Yin;
Chan, Suzanne Suk San;
Ng, Candy Wai Yan;
Cheung, Jana Wing Lan;
Chan, Tina Yee Ching;
Lau, Nike Kwai Cheung;
Chong, Yeow Kuan;
Mak, Tony Wing Lai

Publication type:

Article

Clinical significance of CYP2C19 polymorphisms on the metabolism and pharmacokinetics of 11β-hydroxysteroid dehydrogenase type-1 inhibitor BMS-823778.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 130, doi. 10.1111/bcp.13421

By:

Cheng, Yaofeng;
Wang, Lifei;
Iacono, Lisa;
Zhang, Donglu;
Chen, Weiqi;
Gong, Jiachang;
Humphreys, William Griffith;
Gan, Jinping

Publication type:

Article

Dose-dependent acute liver injury with hypersensitivity features in humans due to a novel microsomal prostaglandin E synthase 1 inhibitor.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 179, doi. 10.1111/bcp.13423

By:

Jin, Yan;
Regev, Arie;
Kam, Jeanelle;
Phipps, Krista;
Smith, Claire;
Henck, Judith;
Campanale, Kristina;
Hu, Leijun;
Hall, D. Greg;
Yang, Xiao Yan;
Nakano, Masako;
McNearney, Terry Ann;
Uetrecht, Jack;
Landschulz, William

Publication type:

Article

Evaluation of the pharmacokinetic drug interaction potential of tivantinib (ARQ 197) using cocktail probes in patients with advanced solid tumours.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 112, doi. 10.1111/bcp.13424

By:

Tachibana, Masaya;
Papadopoulos, Kyriakos P.;
Strickler, John H.;
Puzanov, Igor;
Gajee, Roohi;
Wang, Yibin;
Zahir, Hamim

Publication type:

Article

Drug-drug interaction potential in men treated with enzalutamide: Mind the gap.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 122, doi. 10.1111/bcp.13425

By:

Benoist, Guillemette Emma;
van Oort, Inge M.;
Smeenk, Stella;
Javad, Adrian;
Somford, Diederik M.;
Burger, David M.;
Mehra, Niven;
van Erp, Nielka P.

Publication type:

Article

Impact of non-adherence on the safety and efficacy of uric acid-lowering therapies in the treatment of gout.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 142, doi. 10.1111/bcp.13427

By:

Hill‐McManus, Daniel;
Soto, Elena;
Marshall, Scott;
Lane, Steven;
Hughes, Dyfrig

Publication type:

Article

Pharmacokinetics of multiple doses of co-crystal of tramadol-celecoxib: findings from a four-way randomized open-label phase I clinical trial.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 64, doi. 10.1111/bcp.13428

By:

Videla, Sebastián;
Lahjou, Mounia;
Vaqué, Anna;
Sust, Mariano;
Escriche, Marisol;
Soler, Lluis;
Sans, Artur;
Sicard, Eric;
Gascón, Neus;
Encina, Gregorio;
Plata‐Salamán, Carlos

Publication type:

Article

Factor Xa inhibition by rivaroxaban in the trough steady state can significantly reduce thrombin generation.

Published in:

British Journal of Clinical Pharmacology, 2018, v. 84, n. 1, p. 79, doi. 10.1111/bcp.13429

By:

Horinaka, Shigeo;
Sugawara, Rie;
Yonezawa, Yutaka;
Ishimitsu, Toshihiko

Publication type:

Article